[Current developments in hybridoma technology].

A D, Osterhaus; A G, UytdeHaag

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1986

Data sources: Europe PubMed Central

[Current developments in hybridoma technology].

descriptionPublicationkeyboard_double_arrow_right Article 22 Jan 1986 Dutch; Flemish Journal:Tijdschrift voor diergeneeskunde, volume 110 (issn: 0040-7453,

Copyright policy )

Authors: A D, Osterhaus; A G, UytdeHaag;

pmid: 3878011

[Current developments in hybridoma technology].

- Summary
- Subjects
- Metrics

Abstract

A review of recent developments in hybridoma technology is presented. The advantages and disadvantages of different methods of immunization, immortalization, selection and cultivation of hybridomas are evaluated. Recent and promising developments in the field of the application of monoclonal antibodies are discussed.

Keywords

B-Lymphocytes, Hybridomas, Antibodies, Monoclonal, Cell Line, Rats, Cell Fusion, Mice, Species Specificity, Animals, Humans, Multiple Myeloma

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average